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Circulation Vol 86, No 4 October 1992 tope"l-'4 has been proposed. As an alternative to`01T1 scintigraphy, metabolic imaging using positron emission tomography (PET) also may be used for the detection of viable myocardium. 3, [15] [16] [17] [18] [19] In particular, the identification of viable myocardium from PET studies is based on the presence of either normal '8fluorodeoxyglucose (FDG) uptake or FDG: blood flow mismatch,15 whereas the identification of viable myocardium from`01T1 scintigraphy is based on the presence of either normal`'TI uptake or reversiblè "Tl defects (after either redistribution or reinjection)."1 The accuracy of these criteria to predict an improvement in regional function after revascularization has been evaluated, for both PET and`'Tl scintigraphy with rest-reinjection, in a relatively small number of patients.3,1'"'2 '19 The results of these studies indicate that the current PET and 2"T1 criteria used to identify viable myocardium are quite accurate but not perfect, as they may underestimate viability in up to 22% of the myocardial segments classified as nonviable. '9 In a recent study20 using a quantitative analysis of regional FDG and`'TI uptake, we hypothesized that regions with reduced blood flow and mild-to-moderate reduction in FDG activity (without FDG: blood flow mismatch), as well as regions with mild-to-moderate irreversible 2'Tl defects (after redistribution and/or reinjection), represent viable myocardium. The goal of the present study was to provide confirmatory evidence that these patterns of FDG and "1T1 uptake do indeed represent viable myocardium. To confirm these hypotheses, we used as a "gold standard" for viability the presence of preserved regional anatomy and systolic function evaluated by gated magnetic resonance imaging (MRI), in relation to regional`1TI and FDG activity, in patients with CAD and left ventricular dysfunction.
Methods

Patient Selection
We studied 25 patients with angiographically proven CAD and left ventricular dysfunction. There were 24 men and one woman, ranging in age from 38 to 78 years (mean, 58±9 years). Left ventricular ejection fraction by radionuclide angiography ranged from 11% to 47% (mean, 28+10%) at rest. Although all patients had evidence of previous myocardial infarction, we studied only patients with chronic stable CAD; no patient had an acute myocardial infarction or unstable angina within 6 months of the study. One patient had diabetes mellitus. In the 24 nondiabetic patients, plasma glucose levels before the FDG study were in the normal fasting range (93±+ 18 mg/dl). Coronary arteriography (performed within a mean interval of 8±13 months from the PET study) demonstrated significant stenosis (.50% reduction in luminal diameter) of all three major epicardial coronary arteries in 17 patients and of two coronary arteries in five patients; 21 patients had at least one totally occluded epicardial coronary artery. In 20 patients, all cardiac medications were discontinued for at least 48 hours before radionuclide angiography, ' Tl scintigraphy, PET, and MRI were performed. The remaining five patients underwent all the imaging studies while receiving the same medical regimen for each study; these included nitrate compounds alone (one calcium channel blockers (four patients). An average of 23±26 days (range, 1-83 days) elapsed between performance of the first and the last of these tests. PET and "T1 data have been reported previously in 11 of the 25 patients. 20 Informed written consent for the study protocol was obtained from each patient.
Gated Blood Pool Cardiac Scintigraphy
Gated equilibrium radionuclide angiography was performed at rest with the patients in the supine position using red blood cells labeled in vivo with 20-25 mCi of Tc 99m. High temporal resolution (20 msec per frame) time-activity curves were generated, from which the left ventricular ejection fraction was computed as described previously.2' Regional wall motion analysis demonstrated the presence of regional akinesia or dyskinesia in one or more vascular territories in 17 patients and hypokinesia in the other eight patients.
201T1 Imaging
All patients underwent exercise`'Tl single-photon emission computed tomography (SPECT) as previously described." In brief, after an overnight fast, patients underwent treadmill exercise according to a standardized multistage exercise protocol, with continuous monitoring of heart rate and rhythm, blood pressure, and symptoms. Nineteen (76%) of the 25 patients achieved .85% of predicted maximal heart rate during exercise. Angina developed in 12 patients during exercise and was accompanied by ST segment depression in six patients. Nine additional patients showed ischemic ST changes during exercise without angina. At peak exercise, 2 mCi "'TI was injected intravenously, and the patients continued exercise for an additional 45-60 seconds. Approximately 10 minutes after termination of exercise,`'Tl images were obtained using a wide-fieldof-view rotating gamma camera equipped with a highsensitivity, medium-resolution, parallel-hole collimator centered on the 68-keV photo peak with a 20% window. The camera was rotated in a 1800 arc in an elliptical orbit about the patient's thorax from a right anterior oblique angle of 400 to a left posterior angle of 40°at 60 increments for 30 seconds each."
Redistribution images were obtained 3-4 hours after stress, while the patients were resting. Immediately thereafter, all patients received an additional 1 mCi Perrone-Filardi et al Regional Ventricular Function and Regional FDG and 20'T1 Uptake 1127 transaxial tomograms. To prevent chest movement artifacts, two seat belts were fastened around the patient's thorax during the acquisition of the study and patient positioning was checked periodically by a laser marker.
All PET assumed to represent the normal ratio between FDG uptake and blood flow for that patient. In keeping with the 80% threshold used to define reduced blood flow relative to the normal reference region, regional FDG uptake was defined as reduced when it was <80% of that of the normal reference region.26
Based on the FDG content and on the FDG:blood flow ratio, four groups of myocardial regions were identified: 1) normal (.80% of the FDG activity in the normal reference region associated with normal blood flow), 2) mismatch (reduced myocardial blood flow with FDG:blood flow ratio .110% of that of the normal reference region), 3) moderately reduced FDG uptake (50-79% of normal reference FDG activity with reduced blood flow and FDG:blood flow ratio <110% of that of the normal reference region), 4) severely reduced FDG uptake (<50% of normal reference FDG activity with reduced blood flow and FDG: blood flow ratio <110% of that of the reference region). The choice of an FDG:blood flow ratio .110% of that of the normal region as a cutoff to identify the occurrence of FDG:blood flow mismatch was derived from previously reported data obtained in normal volunteers in which FDG: blood flow values ranged from 1.02 to 1.12 mg/g per minute,27 which is similar to the 1.20 cutoff value used by Vanoverschelde et aV28 to define the occurrence of FDG:blood flow mismatch. In the current analysis, a region could be defined as showing mismatch if FDG activity was normal, increased, or less than normal, as long as FDG activity was disproportionately increased relative to the reduced regional blood flow, as previously described.15
The calculation of blood flow using the H2150 model volume effects. This recovery coefficient is valid not just for the water blood flow data but also for the FDG data extracted from the same ROLs. A similar correction, however, could not be made for the 201TI SPECT data. To avoid biasing the results, the FDG and SPECT comparisons were made with neither data set corrected for recovery coefficient. Similarly, the FDG activity was assessed without correction for the arterial input function.
Regional wall thickness and systolic thickening. To assess regional end-diastolic thickness and absolute wall thickening, corresponding transaxial end-diastolic and end-systolic MRI images were analyzed by two independent operators unaware of '"ln and FDG results.
Alignment of the PET slice with the corresponding MRI slice was done visually, using both the PET attenuation images (which show the lung outlines clearly, the heart shadow, and the slice in which the liver first begins to appear) and the PET emission images. Because of the different interslice distance (5.1 mm for PET and 10 mm for MRI), each MRI tomogram was matched to two contiguous PET tomograms. An average of three MRI slices (range, 1-5) and six FDG and 20`T1 tomographic planes (range, 2-10) were analyzed for each patient. As described above, each PET and SPECT slice had been divided into five ROTs. By appropriate resampling, the PET and MRI images were made to be of identical size (i.e., the same number of mm per pixel). The five ROIs drawn on the PET then could be superimposed visually on the MRI (with appropriate rotations and translations also determined visually). Because each ROI encompassed a relatively large amount of myocardial tissue, minor misalignments using this visual technique would not significantly alter the results. Thickness measurements were made at the center of each ROI by manually identifying a point of the epicardial and endocardial borders perpendicular to the two surfaces. The length of the line segment joining these two points was calculated and taken as the wall thickness. Systolic wall thickening was defined as the difference between end-systolic and end-diastolic wall thickness. Based on the extent of systolic wall thickening, myocardial regions were considered normokinetic (systolic wall thickening >2 mm), hypokinetic (systolic wall thickening <2 mm), or akinetic-dyskinetic (in case of absent wall thickening or of systolic wall thinning).29 A total of 347 myocardial regions were evaluated, which averaged 14 per patient (range, Of the 347 myocardial regions analyzed, 129 showed normal FDG uptake with normal blood flow. The blood flow in these regions (1.1±0.3 ml/g per minute; range, 0.70-2.10 ml/g per minute;) was significantly higher than in all other groups (p<0.01). In 113 regions, reduced blood flow (0.59+±0.17 ml/g per minute; range, 0.20-0.91 ml/g per minute) with increased FDG: blood flow ratio was measured; these were considered to represent regions of FDG: blood flow mismatch. Among the remaining 105 regions with reduced FDG uptake, 69 showed moderately reduced FDG uptake (65±12% of the normal activity) with reduced blood flow (0.70±0.19 ml/g per minute; range, 0.25-1.20 ml/g per minute). The level of blood flow in these regions was significantly greater than that of regions with severely reduced FDG uptake and regions with FDG: blood flow mismatch (p<0.01). The other 36 regions had severely reduced FDG uptake (36±10% of the normal activity) with reduced blood flow (0.59±0.17 ml/g per minute; range, 0.20-0.90 ml/g per minute).
Segmental analysis. The end-diastolic wall thickness (Figure 1 ) in the 69 regions with moderately reduced FDG uptake was significantly greater than that of the 36 regions with severely reduced FDG uptake (9.4±2.6 versus 8.0±3.7 mm; p<0.05). Furthermore, the end-diastolic wall thickness in regions with moderately reduced FDG uptake was similar to that of regions with normal FDG uptake (10.1±3.3 mm). When absolute systolic wall thickening was determined (Figure 1 Figure 4 . Patient analysis. The results of this analysis confirmed those of the segmental analysis (Tables 2 and 3 ). Mild and moderate irreversible 2`1T1 defects after redistribution were observed in 19 and 20 of the 25 patients, respectively, whereas severe irreversible 201T1 defects were observed in 17 patients. In mild and moderate irreversible defects, systolic wall thickening appeared greater as compared with the severe irreversible defects and was similar to that observed in the reversible 2`1T1 defects. The mean systolic wall thickening in the mild irreversible defects was normal in 11 (58%) of the 19 patients in whom these defects were observed; similarly, in the moderate irreversible defects systolic wall thickening was normal in nine (45%) of the 20 patients with such defects. In contrast, systolic wall thickening at rest in the severe 201T1 defects was normal in only two (12%) of the 17 patients in whom these defects were observed ( Figure 5 ).
Patient analysis. Relative FDG uptake did not appear different among the reversible 20`TI defects and the mild or moderate irreversible 2"11T1 defects; all values were higher than those observed in the severe 2"'T1 defects (Table 3 ). The mean relative FDG activity in the severe 201T1 defects was <50% of the normal region in nine (53%) of the 17 patients with such defects. In contrast, mean FDG activity in the moderate irreversible 20`T1 defects after redistribution was <50% in only one (5%) of the 20 patients with such defects and in none of the mild irreversible 20`T1 defects, which were observed in 19 patients. Eight of the 25 patients (32%) did not have severe irreversible 201T1 defects on stress-redistribution imaging. Therefore, in one third of the patients, the interpretation of mild-moderate irreversible 201T1 defects as viable myocardium indicates that stress-redistribution 201T1 scintigraphy alone (without rest-reinjection) would have been of sufficient accuracy in the evaluation of myocardial viability.
Effects of 201Tl Reinjection
Thallium activity relative to FDG activity. Among the regions with severely reduced FDG uptake, 32 20`T1 uptake after reinjection in the myocardial regions with a moderate reduction in FDG uptake was >50% of the normal region in all 20 patients in whom this metabolic pattern was observed. In contrast, the amount of 20`TI uptake after reinjection was >50% in only one (8%) of the 12 patients with a severe reduction in FDG uptake. 20 'Tl reinjection in severe irreversible defects on redistribution imaging. The effects of`'Tl reinjection after redistribution imaging in regions with irreversible 20`T1 defects are presented in Table 5 in relation to FDG activity, end-diastolic wall thickness, and systolic wall thickening. In mild and moderate irreversible`1"Tl defects, no differences in end-diastolic wall thickness and systolic wall thickening or in the mean FDG activity were observed between regions with or without enhanced 20`T1 activity after reinjection.
The results of 20`T reinjection in regions with severe 20`T1 defects are also shown in Table 5 . Twelve (26%) of the 47 regions with severe irreversible 201T1 defects (corresponding to eight of the 17 patients in which such regions were located) showed enhanced 'Tl1 uptake after reinjection, and the remaining 35 regions showed no increase in 20`T1 activity after reinjection. End-diastolic wall thickness was 10±2 mm in the regions that showed enhanced 20`T1 uptake after reinjection and 8±4 mm (p=NS) in those who did not. A trend toward preserved systolic wall thickening was observed in regions that showed increased 201T1 uptake after reinjection (1.6+3.3 mm) as compared with those that did not (-0.6+2.6 mm;p=0.06; Figure 6 ). However, absence of systolic wall thickening at rest was not only observed in 24 (69%) of the myocardial regions without increased 201T1 uptake after reinjection but also in five (42%) of Figure 6 ). Mean FDG activity (expressed relative to that measured in the normal reference region) was also significantly higher (78±24%) in regions that showed enhanced`'TI uptake after reinjection, as compared with mean FDG activity of regions remaining unchanged after reinjection (41±19%; p<O.001) ( Table  5) . Myocardial blood flow was reduced in regions with and without enhanced`0'Tl uptake after reinjection;
however, in regions with severe`Tl defects, which were irreversible after reinjection, myocardial blood flow was significantly lower (p<0.05) as compared with regions that showed enhanced`0'TI uptake after reinjection (Table 5 ). An example of a myocardial region showing a severe '01T1 defect with enhanced`0'Tl uptake after reinjection as well as preserved metabolic activity is illustrated in Figure 2 . Discussion The results of the present study provide confirmatory evidence that, in patients with ischemic left ventricular dysfunction, myocardial regions with a moderate reduction in FDG uptake and blood flow, without FDG: blood flow mismatch, as well as myocardial regions with mild to moderate`'Tl defects after redistribution, represent viable myocardium.
Moderate Versus Severe Reduction in FDG Uptake
The demonstration of preserved metabolic activity by PET, in which the regional uptake of FDG is an estimate of glucose utilization, has been shown in several studies to identify the presence of viable myocardial tissue in patients with CAD and left ventricular dysfunction3J5-20,30-32 and to predict reversal of regional dysfunction after revascularization.3'19 Although these findings have reasonably high predictive accuracy, they may be inaccurate in predicting functional recovery or lack of functional recovery in up to 22% of the myocardial regions analyzed.19 In these previous studies, regions with reduced myocardial blood flow were assumed to represent viable tissue only if those regions demonstrated either an absolute increase in FDG activity or a relative increase in comparison with the reduced blood flow, thereby exhibiting FDG:blood flow mismatch315-20,30-32; any regions with diminished FDG uptake and diminished blood flow but without the occurrence of FDG: blood flow mismatch were considered nonviable, regardless of the severity of reduction in blood flow or FDG uptake. We hypothesized that regions with only a mild or moderate reduction in FDG uptake might represent viable tissue whether or not FDG: blood flow mismatch is present because it is possible that glucose consumption might be reduced in some regions of viable tissue because of reduced perfusion and function.33 This hypothesis is suggested by`01T1 activity in the majority of such regions.20 The findings of the present study confirm that the majority of regions in which FDG uptake is moderately reduced in proportion to reduced blood flow represent viable myocardium, which is evidenced by preserved regional systolic wall thickening.
Although reduced with respect to the normal regions and to regions with FDG: blood flow mismatch, the mean systolic wall thickening of the regions with moderately reduced FDG uptake was significantly greater than that observed in regions with severely reduced FDG uptake. Similarly, end-diastolic wall thickness in regions with moderate reduction in FDG activity was similar to that of normal regions but was significantly higher than that observed in the regions with severely reduced FDG activity. Moreover, when the extent of In contrast, in the regions with severely reduced FDG uptake, end-diastolic wall thickness was reduced as compared with the other regions, and systolic wall thickening was absent in 75% of these regions (Table 1) , which is compatible with the presence of nonviable tissue. [34] [35] [36] Myocardial regions with a severe reduction in FDG uptake also had a high prevalence (83%) of severe irreversible 201T1 defects, which suggests the presence of nonviable myocardium in those territories. The remaining regions with severely reduced FDG uptake showed either mild or moderate irreversible 201T1 defects (6%) or partially reversible defects (11%); no regions in this group had either normal 20`T1 activity or a completely reversible 20`TI defect (Table 4 ). The discordance in a small number of regions with severely reduced FDG uptake in which 'Tln activity suggested viable myocardium might indicate a potential underestimation of viability by the interpretation of FDG uptake, although some error in the alignment process could also contribute to this discrepancy. The pattern of a moderate reduction in FDG uptake and blood flow, without FDG: blood flow mismatch, probably represents a region of myocardium with a mixture of viable and nonviable tissue. Although it could be argued that no improvement in wall motion would occur after revascularization in these areas, as FDG: blood flow mis- http://circ.ahajournals.org/ match was absent, the 201T1 findings together with the finding of preserved wall thickening strongly suggests the presence of underperfused jeopardized myocardium in these regions. Whether the extent of viable tissue in these regions is sufficient to result in improved regional function after restoration of blood flow will require additional studies in patients undergoing revascularization.
Mild-Moderate Versus Severe 20'T1 Defects
The`"Tl reinjection protocol we used in this study has been recently shown to predict reliably the functional recovery of regions with apparently irreversible defects on standard exercise-redistribution imaging,11"12 with an accuracy similar to that reported using FDG imaging with PET.3'19 Although these`lTl results have been thus far validated in a relatively small number of patients undergoing revascularization,11""2 the number of patients so studied is similar to those reported using PET (Figure 3 ). Myocardial regions with mild or moderate irreversible 20`TI defects, however, manifested reduced but maintained systolic wall thickening, which was similar to that of regions with reversible`'TI defects but was significantly greater than that of regions with severe irreversible defects ( Figure 3) . Moreover, 49% of the regions with mild-moderate irreversible 20`TI defects (corresponding to 51% of the patients in which such defects were observed) showed presence of normal wall motion at rest (Table 2) , and only 19% of the mildmoderate irreversible 20`TI defects showed absent wall thickening. In contrast, systolic wall thickening was absent in 62% of the regions with severe 201T1 defects. Finally, the presence of metabolic activity, as assessed by FDG uptake, was identified in 98% of these segments ( Figure 5) . Therefore, the functional characteristics of these territories together with the metabolic evidence indicate the presence of viable myocardium in mild and moderate irreversible 20`T1 defects after redistribution; this is in agreement with a previous report by Gibson et al. 6 These findings suggest that patients with irreversible 20`TI defects on redistribution imaging, in which the magnitude of the 201T1 defects is not severe, may not require any further investigation to assess the viability of those segments.
Among regions with mild or moderate irreversible 201T1 defects, no differences in systolic wall thickening, end-diastolic wall thickness, or FDG activity were observed between regions with and those without enhanced`"Tl uptake after reinjection (Tables 2 and 5 ). This observation may be accounted for by the relative nature of the`lTl analysis. Regional 20'TI activity in each of the stress, redistribution, and reinjection images was expressed relative to that of a normal reference region. Thus, a substantial increase in absolute 20`T1 activity within the defect after reinjection might be masked by comparable or even greater uptake of 20`T1 in the normal region, and, therefore, result in the appearance of a persistent defect. Recent data in our laboratory, in which absolute as well as relative increases iǹ 'Tl activity were assessed after reinjection, indicate that the absolute uptake of 20`T1 is significantly greater in mild-to-moderate defects that persist after reinjection than in severe persistent defects. 37 Our data also provide additional observations on severe irreversible 20`T1 defects on redistribution images. 
